|
C11ORF46 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.08190000478604E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.16180000462063E-08 |
| Normal-vs-Stage2 |
7.057300E-03 |
| Normal-vs-Stage3 |
4.157500E-04 |
| Normal-vs-Stage4 |
1.31740000020031E-08 |
| Stage1-vs-Stage2 |
2.306800E-01 |
| Stage1-vs-Stage3 |
4.541000E-01 |
| Stage1-vs-Stage4 |
4.566000E-01 |
| Stage2-vs-Stage3 |
6.805800E-01 |
| Stage2-vs-Stage4 |
1.840000E-01 |
| Stage3-vs-Stage4 |
2.677600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.19299999563106E-08 |
| Normal-vs-AfricanAmerican |
9.64230000000121E-05 |
| Normal-vs-Asian |
1.978400E-02 |
| Caucasian-vs-AfricanAmerican |
2.515400E-01 |
| Caucasian-vs-Asian |
7.156000E-01 |
| AfricanAmerican-vs-Asian |
9.679400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.89730494940477E-11 |
| Normal-vs-Female |
1.822380E-03 |
| Male-vs-Female |
2.198700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.2797999999935E-05 |
| Normal-vs-Extreme_Weight |
8.06579999457213E-08 |
| Normal-vs-Obese |
7.51330000000605E-05 |
| Normal-vs-Extreme_Obese |
1.756860E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.373800E-01 |
| Normal_Weight-vs-Obese |
8.606800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.191800E-01 |
| Extreme_Weight-vs-Obese |
2.211800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.575400E-01 |
| Obese-vs-Extreme_Obese |
8.447600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.003830E-01 |
| Normal-vs-Age(41-60Yrs) |
1.55933999999025E-05 |
| Normal-vs-Age(61-80Yrs) |
5.57729995520617E-09 |
| Normal-vs-Age(81-100Yrs) |
3.93899999999725E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.648010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.504190E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.569700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.988110E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.570350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.918800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.49890055501612E-10 |
| Normal-VS-Type2 PRCC |
1.45530000050798E-07 |
| Normal-VS-KIRP CIMP |
2.935400E-01 |
| Normal-VS-Unclassified PRCC |
1.220360E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.327400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.674000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.159250E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.079760E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.576800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.187400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73180000842643E-09 |
| Normal-vs-N1 |
3.225700E-02 |
| Normal-vs-N2 |
1.629250E-04 |
| N0-vs-N1 |
4.174200E-02 |
| N0-vs-N2 |
1.872030E-01 |
| N1-vs-N2 |
7.809600E-02 |
|
|
